2 Results for "

mRNA cap substrate

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "mRNA cap substrate" in MCE Product Catalog:

Cat. No.: HY-170524
CAS No.: 3052313-73-9
Research Areas:  

Infection

TDI-015051 is a highly selective, orally active antiviral agent that targets the coronavirus NSP14 guanine-N7 methyltransferase. TDI-015051 binds to substrates in a non-competitive manner and forms a stable ternary complex, precisely blocking the capping and methylation processes of viral mRNA. TDI-015051 potently inhibits a variety of coronaviruses (including SARS-CoV-2 and MERS). By impairing viral replication and translation and inducing a moderate type I interferon-mediated immune response, it significantly reduces pulmonary viral load and exhibits a synergistic effect with Nirmatrelvir (HY-138687). In addition, TDI-015051 does not inhibit non-coronavirus methyltransferases, and the drug-resistant mutations it induces impair viral fitness, demonstrating excellent antiviral properties and safety. TDI-015051 can be used for research on COVID-19 and the replication mechanism of coronaviruses .The IC50 values of TDI-015051 against SARS-CoV-2, α-hCoV-NL63, α-hCoV-229E, β-hCoV-MERS are 0.15 nM, 1.7 nM, 2.6 nM and 3.6 nM, respectively, and the Ka value against SARS-CoV-2 is 0.061 nM .
loading...
    loading...
Cat. No.: HY-189094
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

DcpS-IN-1 is an orally active DcpS inhibitor with an IC50 of 0.16 nM against hDcpS. DcpS-IN-1 exhibits anticancer activity against lung squamous cell carcinoma and head and neck squamous cell carcinoma. DcpS-IN-1 can be used in the research of solid tumors .
loading...
    loading...